Welcome to Pedagogy   |   Sign In

CBD - What Are The Claims?

Marketed as help for anxiety, depression and more but how to reap the benefits of CBD without the "high".

CBD is advertised as providing relief for anxiety, depression and post-traumatic stress disorder. It is also marketed to promote sleep. Part of CBD’s popularity is that it purports to be “nonpsychoactive,” and that consumers can reap health benefits from the plant without the high (or the midnight pizza munchies).

Just as hemp seedlings are sprouting up across the United States, so is the marketing. From oils and nasal sprays to lollipops and suppositories, it seems no place is too sacred for CBD. “It’s the monster that has taken over the room,” Dr. Brad Ingram, an associate professor of pediatrics at the University of Mississippi Medical Center, said about all the wild uses for CBD now. He is leading a clinical trial into administering CBD to children and teenagers with drug-resistant epilepsy.

Does CBD work?

“It’s promising in a lot of different therapeutic avenues because it’s relatively safe,” said James MacKillop, co-director of McMaster University’s Michael G. DeGroote Center for Medicinal Cannabis Research in Hamilton, Ontario.

Last year, the F.D.A. approved Epidiolex, a purified CBD extract, to treat rare seizure disorders in patients 2 years or older after three randomized, double-blind and placebo-controlled clinical trials with 516 patients that showed the drug, taken along with other medications, helped to reduce seizures. These types of studies are the gold standard in medicine, in which participants are divided by chance, and neither the subject nor the investigator knows which group is taking the placebo or the medication.

While there is hope for treating other conditions with the plant extract, Epidiolex remains the only CBD-derived drug approved by the F.D.A. Most of the research on cannabidiol has been in animals, and its current popularity has outpaced science. “We don’t have the 101 course on CBD quite figured out yet,” said Ryan Vandrey, an associate professor of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine.

New York Times
To read this article in its entirety click HERE.

For nurses and other healthcare professionals wanting to learn more about CBD, consider taking our CBD 101: An Introductory Course

CBD (in the form of oils, creams, lotions, edibles and more) has entered mainstream America! Their presence has been noted in the fields of food and beverages, cosmetics, and pharmaceuticals. With projections for this industry to surpass $20 billion dollars by the year 2024, healthcare providers need to be aware of the ever-growing consumer usage, as well as the medical and legal implications for its users.

CBD is defined as cannabidiol. It is an active chemical in the Cannabis Sativa plant (also known as marijuana or hemp). While CBD is one of over 80 chemicals (known as cannabinoids), by itself it does not cause a “high”. According to the World Health Organization, CBD exhibits no effects indicative of any abuse or dependence potential. Furthermore, to date, there is no evidence of public health-related problems associated with the use of pure CBD. The issue at hand is actually the origin of the CBD ingredients. While delta-9-tetrahydrocannabinol (THC) is the major active ingredient in marijuana, cannabidiol is also obtained from hemp, which contains only very small amounts of THC.


The purpose of the continuing education program is to inform and educate healthcare providers on the various forms of CBD and their usage in mainstream medicine. Upon completion of this course participants will be able to:

Discuss the origins of CBD usage
Verbalize differences between marijuana-based and hemp-based CBD products
Identify recognized usages for CBD (disease-specific)
Discuss route of administration for CBD usage
Discuss components of the farming hemp bill
Verbalize federal laws related to CBD usage (healthcare workers and urine drugs screens)
Discuss medical marijuana act/medical compassion act
Identify state rules regarding CBD
Acknowledge the need for additional research to identify CBD based products that offer optimal benefit with minimal risk


Chapter 1

Chapter 2

Chapter 3
The Endocannabinoid System

Chapter 4
CBD Availabel Routes Of Administration

Chapter 5
CBD And Medical Treatments (Condition Specific)
Insufficient Evidence

Chapter 6
CBD And Known Side Effects
The Entourage Effect

Chapter 7
National Institutes Of Health (NIH) Views On CBD
Centers For Disease Control and Prevention (CDC) and CBD
World Health Organization (WHO) and CBD

Chapter 8
Medical Compassion Program
Legal Issues: Urine Drug Screens

Chapter 9
Farming Hemp Bill

Chapter 10
CBD And The American Cannabis Nurse Association (ACNA)

Chapter 11

Pedagogy course are available for purchase by the individual. Register with us to create your log in and password, click on the course title of interest and then click the BUY NOW button.     Or for a complete listing of all our online continuing education courses Click HERE.  

Pedagogy Newsletter
Subscribe to Pedagogy's Quarterly Newsletter


Copyright © 2020 Pedagogy, Inc. All Rights Reserved.

Powered by Kentico